The transition to end-of-life care in end-stage liver disease

Paula Cox-North, Ardith Doorenbos, Sarah Shannon, John Scott, Jared Randall Curtis

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

In the United States, end-stage liver disease (ESLD) is the 12th leading cause of death and the 7th leading cause of death in people between the ages of 25 and 64 years. Complications of ESLD such as ascites, variceal hemorrhage, hepatic encephalopathy, and renal impairment primarily account for these deaths. Patients with ESLD require increasingly complex medical support and manifest a spectrum of complications and symptoms that have significant impact on both survival and quality of life.Because of the possibility of liver transplantation, patients with ESLD are more likely to receive aggressive care despite constant declining poor health. In current practice, discussions and referrals to palliative or hospice care are not done until the hope of recovery is diminished, which is often in the last weeks of life. There is little literature on the appropriate palliative care approach for those with ESLD. The purpose of this article is to summarize the transitions often experienced by patients with ESLD as they approach end-of-life, compare and contrast these transitions to other life limiting illnesses, and review current palliative care strategies recommended for ESLD.

Original languageEnglish (US)
Pages (from-to)209-215
Number of pages7
JournalJournal of Hospice and Palliative Nursing
Volume15
Issue number4
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

End Stage Liver Disease
Terminal Care
Palliative Care
Cause of Death
Hospice Care
Hepatic Encephalopathy
Ascites
Liver Transplantation
Referral and Consultation
Quality of Life
Hemorrhage
Kidney
Survival
Health

Keywords

  • communication
  • decisional capacity
  • end of life
  • end-stage liver disease
  • palliative care

ASJC Scopus subject areas

  • Advanced and Specialized Nursing
  • Community and Home Care

Cite this

Cox-North, P., Doorenbos, A., Shannon, S., Scott, J., & Curtis, J. R. (2013). The transition to end-of-life care in end-stage liver disease. Journal of Hospice and Palliative Nursing, 15(4), 209-215. https://doi.org/10.1097/NJH.0b013e318289f4b0

The transition to end-of-life care in end-stage liver disease. / Cox-North, Paula; Doorenbos, Ardith; Shannon, Sarah; Scott, John; Curtis, Jared Randall.

In: Journal of Hospice and Palliative Nursing, Vol. 15, No. 4, 06.2013, p. 209-215.

Research output: Contribution to journalReview article

Cox-North, P, Doorenbos, A, Shannon, S, Scott, J & Curtis, JR 2013, 'The transition to end-of-life care in end-stage liver disease', Journal of Hospice and Palliative Nursing, vol. 15, no. 4, pp. 209-215. https://doi.org/10.1097/NJH.0b013e318289f4b0
Cox-North, Paula ; Doorenbos, Ardith ; Shannon, Sarah ; Scott, John ; Curtis, Jared Randall. / The transition to end-of-life care in end-stage liver disease. In: Journal of Hospice and Palliative Nursing. 2013 ; Vol. 15, No. 4. pp. 209-215.
@article{f3b40ccfa2f44907acb55bb4125fa587,
title = "The transition to end-of-life care in end-stage liver disease",
abstract = "In the United States, end-stage liver disease (ESLD) is the 12th leading cause of death and the 7th leading cause of death in people between the ages of 25 and 64 years. Complications of ESLD such as ascites, variceal hemorrhage, hepatic encephalopathy, and renal impairment primarily account for these deaths. Patients with ESLD require increasingly complex medical support and manifest a spectrum of complications and symptoms that have significant impact on both survival and quality of life.Because of the possibility of liver transplantation, patients with ESLD are more likely to receive aggressive care despite constant declining poor health. In current practice, discussions and referrals to palliative or hospice care are not done until the hope of recovery is diminished, which is often in the last weeks of life. There is little literature on the appropriate palliative care approach for those with ESLD. The purpose of this article is to summarize the transitions often experienced by patients with ESLD as they approach end-of-life, compare and contrast these transitions to other life limiting illnesses, and review current palliative care strategies recommended for ESLD.",
keywords = "communication, decisional capacity, end of life, end-stage liver disease, palliative care",
author = "Paula Cox-North and Ardith Doorenbos and Sarah Shannon and John Scott and Curtis, {Jared Randall}",
year = "2013",
month = "6",
doi = "10.1097/NJH.0b013e318289f4b0",
language = "English (US)",
volume = "15",
pages = "209--215",
journal = "Journal of Hospice and Palliative Nursing",
issn = "1522-2179",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The transition to end-of-life care in end-stage liver disease

AU - Cox-North, Paula

AU - Doorenbos, Ardith

AU - Shannon, Sarah

AU - Scott, John

AU - Curtis, Jared Randall

PY - 2013/6

Y1 - 2013/6

N2 - In the United States, end-stage liver disease (ESLD) is the 12th leading cause of death and the 7th leading cause of death in people between the ages of 25 and 64 years. Complications of ESLD such as ascites, variceal hemorrhage, hepatic encephalopathy, and renal impairment primarily account for these deaths. Patients with ESLD require increasingly complex medical support and manifest a spectrum of complications and symptoms that have significant impact on both survival and quality of life.Because of the possibility of liver transplantation, patients with ESLD are more likely to receive aggressive care despite constant declining poor health. In current practice, discussions and referrals to palliative or hospice care are not done until the hope of recovery is diminished, which is often in the last weeks of life. There is little literature on the appropriate palliative care approach for those with ESLD. The purpose of this article is to summarize the transitions often experienced by patients with ESLD as they approach end-of-life, compare and contrast these transitions to other life limiting illnesses, and review current palliative care strategies recommended for ESLD.

AB - In the United States, end-stage liver disease (ESLD) is the 12th leading cause of death and the 7th leading cause of death in people between the ages of 25 and 64 years. Complications of ESLD such as ascites, variceal hemorrhage, hepatic encephalopathy, and renal impairment primarily account for these deaths. Patients with ESLD require increasingly complex medical support and manifest a spectrum of complications and symptoms that have significant impact on both survival and quality of life.Because of the possibility of liver transplantation, patients with ESLD are more likely to receive aggressive care despite constant declining poor health. In current practice, discussions and referrals to palliative or hospice care are not done until the hope of recovery is diminished, which is often in the last weeks of life. There is little literature on the appropriate palliative care approach for those with ESLD. The purpose of this article is to summarize the transitions often experienced by patients with ESLD as they approach end-of-life, compare and contrast these transitions to other life limiting illnesses, and review current palliative care strategies recommended for ESLD.

KW - communication

KW - decisional capacity

KW - end of life

KW - end-stage liver disease

KW - palliative care

UR - http://www.scopus.com/inward/record.url?scp=84877702660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877702660&partnerID=8YFLogxK

U2 - 10.1097/NJH.0b013e318289f4b0

DO - 10.1097/NJH.0b013e318289f4b0

M3 - Review article

AN - SCOPUS:84877702660

VL - 15

SP - 209

EP - 215

JO - Journal of Hospice and Palliative Nursing

JF - Journal of Hospice and Palliative Nursing

SN - 1522-2179

IS - 4

ER -